These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8537670)

  • 41. The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock.
    Rogy MA; Oldenburg HS; Calvano SE; Montegut WJ; Stackpole SA; Van Zee KJ; Marra MN; Scott RW; Seilhammer JJ; Moldawer LL
    J Clin Immunol; 1994 Mar; 14(2):120-33. PubMed ID: 8195314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipopolysaccharide (LPS)-specific monoclonal antibodies regulate LPS uptake and LPS-induced tumor necrosis factor-alpha responses by human monocytes.
    Pollack M; Espinoza AM; Guelde G; Koles NL; Wahl LM; Ohl CA
    J Infect Dis; 1995 Sep; 172(3):794-804. PubMed ID: 7658073
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A recombinant amino terminal fragment of bactericidal/permeability-increasing protein inhibits the induction of leukocyte responses by LPS.
    Mészáros K; Parent JB; Gazzano-Santoro H; Little R; Horwitz A; Parsons T; Theofan G; Grinna L; Weickmann J; Elsbach P
    J Leukoc Biol; 1993 Dec; 54(6):558-63. PubMed ID: 8245707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J; Elsbach P; Shu C; Castillo J; Grinna L; Horwitz A; Theofan G
    J Clin Invest; 1992 Sep; 90(3):1122-30. PubMed ID: 1522221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction.
    Hubacek JA; Pitha J; Skodová Z; Adámková V; Podrapska I; Schmitz G; Poledne R
    Clin Chem Lab Med; 2002 Nov; 40(11):1097-100. PubMed ID: 12521224
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Arabidopsis LBP/BPI related-1 and -2 bind to LPS directly and regulate PR1 expression.
    Iizasa S; Iizasa E; Matsuzaki S; Tanaka H; Kodama Y; Watanabe K; Nagano Y
    Sci Rep; 2016 Jun; 6():27527. PubMed ID: 27273538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Presence of bactericidal/permeability-increasing protein in human and rat skin.
    Takahashi M; Horiuchi Y; Tezuka T
    Exp Dermatol; 2004 Jan; 13(1):55-60. PubMed ID: 15009116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia.
    Levy O; Canny G; Serhan CN; Colgan SP
    Biochem Soc Trans; 2003 Aug; 31(Pt 4):795-800. PubMed ID: 12887308
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Design of a potent novel endotoxin antagonist.
    Uknis ME; Wasiluk KR; Acton RD; Klaerner HG; Dahlberg PS; Ilyina EE; Haseman JR; Gray BH; Mayo KH; Dunn DL
    Surgery; 1997 Aug; 122(2):380-5. PubMed ID: 9288144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins.
    Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC
    J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C; Weiss J
    J Immunol; 1996 Jun; 156(12):4789-96. PubMed ID: 8648126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. OmpR-dependent and OmpR-independent responses of Escherichia coli to sublethal attack by the neutrophil bactericidal/permeability increasing protein.
    Prohinar P; Forst SA; Reed D; Mandic-Mulec I; Weiss J
    Mol Microbiol; 2002 Mar; 43(6):1493-504. PubMed ID: 11952900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
    Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
    Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin.
    Elsbach P
    Ciba Found Symp; 1994; 186():176-87; discussion 187-9. PubMed ID: 7768151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individual and synergistic effects of rabbit granulocyte proteins on Escherichia coli.
    Levy O; Ooi CE; Weiss J; Lehrer RI; Elsbach P
    J Clin Invest; 1994 Aug; 94(2):672-82. PubMed ID: 8040321
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
    Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased bactericidal/permeability increasing protein in patients with cirrhosis.
    Guerra-Ruiz A; Casafont F; Cobo M; Terán A; de-la-Peña J; Estebanez A; Pons-Romero F
    Liver Int; 2010 Jan; 30(1):94-101. PubMed ID: 19765220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Presence of bactericidal/permeability-increasing protein in disease: detection by ELISA.
    Dentener MA; Francot GJ; Smit FT; Froon AH; Pennings HJ; Wouters EF; Buurman WA
    J Infect Dis; 1995 Mar; 171(3):739-43. PubMed ID: 7876632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.